We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Volumetric Coiling in Aneurysm Registry of the Penumbra Coil 400TM System in France (VOLCAN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01754051
Recruitment Status : Recruiting
First Posted : December 21, 2012
Last Update Posted : September 28, 2016
Information provided by (Responsible Party):
Penumbra Inc.

Brief Summary:
This study is a prospective, multi-center registry of patients with intracranial aneurysms who are treated by the PC 400 System. Data for each patient are collected up to 12 ± 3 months post-procedure for the study.

Condition or disease Intervention/treatment
Intracranial Aneurysms Device: PC 400 coils

Study Type : Observational [Patient Registry]
Estimated Enrollment : 200 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 1 Year
Official Title: VOLCAN: A Volumetric Coiling in Aneurysm Registry of the Penumbra Coil 400TM System in France
Study Start Date : January 2013
Estimated Primary Completion Date : December 2017
Estimated Study Completion Date : December 2017

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort Intervention/treatment
Treatment by the PC 400 coils Device: PC 400 coils

Primary Outcome Measures :
  1. Packing density with the number of coils implanted [ Time Frame: During the procedure ]
  2. Time of fluoroscopic exposure [ Time Frame: During the procedure ]
  3. Procedural device-related serious adverse events at immediate post-procedure [ Time Frame: During the procedure ]
  4. Quality of aneurysm occlusion post-operatively and at 12±3 months post-procedure based on the Raymond Scale [ Time Frame: At 1 year post-procedure ]

Secondary Outcome Measures :
  1. Acute occlusion of the aneurysm sac at immediate post-procedure [ Time Frame: At immediate post-procedure ]
  2. Adverse events occurring during the procedure and in the 30±7 days following the treatment. [ Time Frame: During and at 30 days post-procedure ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Up to 200 patients with intracranial aneurysms treated by the PC 400 System at up to 20 centers will be enrolled.

Inclusion Criteria:

  • Patients older than 18 years
  • Intracranial aneurysms >2mm, ruptured or unruptured

Exclusion Criteria:

  • Fusiform aneurysms
  • Dissecting aneurysms
  • Aneurysms associated with brain AVMs
  • Multiple aneurysms
  • Re-treated aneurysms
  • Patients in whom endovascular embolization therapies other than PC 400 System are used will be excluded from this study. However, adjunctive use of balloon and stent are acceptable.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01754051

Contact: Rosio Barraza, MS 510 748 3200 rbarraza@penumbrainc.com
Contact: Siu Po Sit, PhD 510748 3200 ext 221 siupo.sit@penumbrainc.com

Hôpital Côte de Nacre Recruiting
Caen Cedex 9, France
Contact: Prof. Patrick Courthéoux, MD         
Principal Investigator: Prof. Patrick Courthéoux, MD         
CHU Reims - Hôpital Maison Blanche Recruiting
Reims Cedex, France
Contact: Prof. Laurent Pierot, MD         
Principal Investigator: Prof. Laurent Pierot, MD         
Sponsors and Collaborators
Penumbra Inc.
Principal Investigator: Prof. Laurent Pierot, MD CHU Reims - Hôpital Maison Blanche

Responsible Party: Penumbra Inc.
ClinicalTrials.gov Identifier: NCT01754051     History of Changes
Other Study ID Numbers: CLP 4818
CLP 4818 ( Other Identifier: Penumbra Inc )
First Posted: December 21, 2012    Key Record Dates
Last Update Posted: September 28, 2016
Last Verified: September 2016

Additional relevant MeSH terms:
Intracranial Aneurysm
Vascular Diseases
Cardiovascular Diseases
Intracranial Arterial Diseases
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases